Ameriprise’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-680
| Closed | -$3K | – | 3809 |
|
|
2018
Q2 | $3K | Hold |
680
| – | – | ﹤0.01% | 3621 |
|
|
2018
Q1 | $5K | Hold |
680
| – | – | ﹤0.01% | 3609 |
|
|
2017
Q4 | $5K | Buy |
680
+25
| +4% | +$184 | ﹤0.01% | 3621 |
|
|
2017
Q3 | $5K | Hold |
655
| – | – | ﹤0.01% | 3654 |
|
|
2017
Q2 | $7K | Hold |
655
| – | – | ﹤0.01% | 3705 |
|
|
2017
Q1 | $8K | Hold |
655
| – | – | ﹤0.01% | 3588 |
|
|
2016
Q4 | $8K | Hold |
655
| – | – | ﹤0.01% | 3840 |
|
|
2016
Q3 | $12K | Hold |
655
| – | – | ﹤0.01% | 3730 |
|
|
2016
Q2 | $7K | Sell |
655
-111
| -14% | -$1.19K | ﹤0.01% | 3725 |
|
|
2016
Q1 | $14K | Hold |
766
| – | – | ﹤0.01% | 3703 |
|
|
2015
Q4 | $20K | Hold |
766
| – | – | ﹤0.01% | 3799 |
|
|
2015
Q3 | $35K | Hold |
766
| – | – | ﹤0.01% | 3760 |
|
|
2015
Q2 | $25K | Sell |
766
-44
| -5% | -$1.44K | ﹤0.01% | 3936 |
|
|
2015
Q1 | $26K | Buy |
+810
| New | +$26K | ﹤0.01% | 3748 |
|
|
2014
Q4 | – | Sell |
-418
| Closed | -$11K | – | 4765 |
|
|
2014
Q3 | $11K | Buy |
418
+56
| +15% | +$1.47K | ﹤0.01% | 4774 |
|
|
2014
Q2 | $11K | Buy |
362
+7
| +2% | +$213 | ﹤0.01% | 4614 |
|
|
2014
Q1 | $13K | Hold |
355
| – | – | ﹤0.01% | 4412 |
|
|
2013
Q4 | $15K | Sell |
355
-973
| -73% | -$41.1K | ﹤0.01% | 4196 |
|
|
2013
Q3 | $71K | Sell |
1,328
-160
| -11% | -$8.55K | ﹤0.01% | 3629 |
|
|
2013
Q2 | $80K | Buy |
+1,488
| New | +$80K | ﹤0.01% | 3474 |
|